Sharon R Lewin Selected Research

Sharon R Lewin Research Topics

Disease

49	Infections 06/2023 - 03/2002
36	HIV Infections (HIV Infection) 10/2022 - 10/2002
27	Coinfection 03/2024 - 03/2005
12	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 07/2005
11	Neoplasms (Cancer) 02/2022 - 01/2011
10	COVID-19 11/2023 - 01/2021
10	Latent Infection 01/2021 - 10/2011
9	Fibrosis (Cirrhosis) 03/2024 - 11/2007
9	Liver Diseases (Liver Disease) 03/2024 - 07/2008
9	Inflammation (Inflammations) 03/2024 - 11/2007
9	Viremia 01/2023 - 05/2013
8	Hepatitis B 09/2023 - 07/2002
8	Hepatitis 06/2021 - 07/2002
8	Cryptococcal Meningitis 01/2019 - 08/2013
7	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 09/2008
7	Chronic Hepatitis B 06/2021 - 07/2002
6	Immune Reconstitution Inflammatory Syndrome 01/2019 - 07/2008
5	Cryptococcosis 01/2019 - 08/2013
4	Disease Progression 01/2019 - 03/2005
3	Melanoma (Melanoma, Malignant) 01/2021 - 02/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2016 - 03/2011
2	Chronic Disease (Chronic Diseases) 01/2023 - 11/2013
2	Non-alcoholic Fatty Liver Disease 12/2019 - 01/2019
2	Virus Diseases (Viral Diseases) 01/2018 - 12/2017
1	Persistent Infection 10/2023
1	Severe Acute Respiratory Syndrome 10/2022
1	Pancreatitis 10/2022
1	Disseminated Intravascular Coagulation 10/2022
1	Ataxia (Dyssynergia) 01/2022
1	Type I Syndactyly 01/2022
1	Lethargy 01/2022
1	Confusion (Bewilderment) 01/2022

Drug/Important Bio-Agent (IBA)

18	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2008
15	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2007
9	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2002
8	Hepatitis B e AntigensIBA 06/2021 - 09/2008
8	Tenofovir (Viread)FDA Link 01/2020 - 04/2009
7	VaccinesIBA 11/2023 - 07/2002
6	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2011
6	ChemokinesIBA 01/2023 - 12/2007
6	Antiviral Agents (Antivirals)IBA 10/2022 - 02/2003
6	AntigensIBA 07/2021 - 07/2002
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 07/2002
5	LipopolysaccharidesIBA 10/2016 - 04/2011
5	Lamivudine (Epivir)FDA Link 01/2016 - 07/2002
4	enhanced green fluorescent proteinIBA 12/2019 - 06/2010
4	Alanine Transaminase (SGPT)IBA 01/2016 - 07/2008
4	Lipopolysaccharide ReceptorsIBA 09/2014 - 03/2011
3	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2018
3	IpilimumabIBA 10/2021 - 02/2015
3	NivolumabIBA 10/2021 - 01/2018
3	CytokinesIBA 06/2021 - 01/2011
3	InterferonsIBA 06/2021 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 05/2013
3	Histone Deacetylase InhibitorsIBA 09/2020 - 01/2011
3	Interleukin-7 (Interleukin 7)IBA 10/2017 - 01/2011
3	Chemokine ReceptorsIBA 01/2016 - 11/2013
2	HMGB1 Protein (HMG1)IBA 03/2024 - 01/2023
2	nafamostatIBA 11/2023 - 10/2022
2	pembrolizumabIBA 01/2022 - 01/2018
2	Disulfiram (Antabuse)FDA Link 01/2022 - 12/2015
2	Nucleic AcidsIBA 07/2021 - 06/2010
2	LuciferasesIBA 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2014
2	Vorinostat FDA Link 09/2020 - 07/2013
2	LigandsIBA 01/2019 - 12/2007
2	Emtricitabine (Emtriva)FDA Link 01/2016 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014 - 11/2007
2	EnzymesIBA 09/2014 - 10/2009
2	Immunoglobulins (Immunoglobulin)IBA 01/2012 - 07/2002
2	AntibodiesIBA 07/2011 - 10/2009
2	prostratinIBA 04/2011 - 01/2011
2	RacivirIBA 01/2010 - 08/2009
1	mRNA VaccinesIBA 11/2023
1	COVID-19 VaccinesIBA 11/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2023
1	AlarminsIBA 01/2023
1	venetoclaxIBA 01/2023
1	CD4 Antigens (CD4 Antigen)IBA 01/2023
1	S63845IBA 01/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2022
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2022
1	Galectin 1 (LGALS1)IBA 01/2022
1	RNA Splice SitesIBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	Neutralizing AntibodiesIBA 07/2021
1	B-Cell Activating FactorIBA 06/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021

Therapy/Procedure

45	Therapeutics 03/2024 - 03/2005
23	Art Therapy 03/2024 - 10/2009
22	Highly Active Antiretroviral Therapy (HAART) 10/2017 - 02/2007
3	Immunotherapy 01/2021 - 01/2016
3	Aftercare (After-Treatment) 05/2020 - 10/2002
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2016
2	Cesarean Section (Caesarean Section) 01/2012 - 08/2008
1	Withholding Treatment 01/2023
1	Stem Cell Transplantation 01/2022
1	Transplantation 01/2022
1	Intravenous Administration 01/2022